The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use;Skuteczność trazodonu w leczeniu bezsenności pierwotnej u pacjentów nieprzyjmuja̧cych leków nasennych i przyjmuja̧cych je w przeszłości

Polski Merkuriusz Lekarski

Volumn 23, Issue 133, 2007, Pages 41-46

  Wichniak, Adam ^a,b,c   Wierzbicka, Aleksandra ^a,b   Sobańska, Anna ^a,b   Szatkowska, Eugenia ^a,b   Czasak, Krystyna ^a,b   Musińska, Iwona ^a,b   Jernajczyk, Wojciech ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b Third Department of Psychiatry ^*

^c Instytut Psychiatrii i Neurologii III Klinika Psychiatryczna Warszawa   (Poland)

Author keywords

Actigraphy; Pharmacological treatment; Primary insomnia; Trazodone

Indexed keywords

ANTIDEPRESSANT AGENT; HYPNOTIC SEDATIVE AGENT; TRAZODONE;

AGED; ANAMNESIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; INSOMNIA; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; QUESTIONNAIRE; SLEEP; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; POLYSOMNOGRAPHY; QUESTIONNAIRES; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TRAZODONE; TREATMENT OUTCOME;

EID: 34547749530     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Belanger L., Vallieres A., Ivers H. I wsp.: Meta-analysis of sleep changes in control groups of insomnia treatment trials. J. Sleep Res., 2007, 16, 77-84.
2. Borbely A.A., Mattmann P., Loepfe M. I wsp.: Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum. Neurobiol., 1985, 4, 189-194.
3. de Jonghe F., Swinkels J.A.: The safety of antidepressants. Drugs, 1992, 43 Suppl 2, 40-46.
4. Haria M., Fitton A., McTavish D.: Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging, 1994, 4, 331-355.
5. Jarema M., Kiejna A., Landowski J. i wsp.: Standardy leczenia farmakologicznego schizofrenii. Psychiatr. Pol., 2006, 40, 1171-1205.
6. Kaynak H., Kaynak D., Gozukirmizl E. i wsp.: The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med., 2004, 5, 15-20.
7. Krysiak K., Jarema M.: Depresja i bezsenność. Wiad. Psych., 2006, 9, 99-107.
8. Kupfer D.J.: REM latency: a psychobiologic marker for primary depressive disease. Biol. Psychiatry, 1976, 11, 159-174.
9. Le Bon O., Murphy J.R., Staner L. i wsp.: Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: Polysomnographic and clinical evaluations. J. Clin. Psychopharmacol., 2003, 23, 377-383.
10. Lebert F., Pasquier F., Petit H.: Behavioral effects of trazodone in Alzheimer's disease. J. Clin. Psychiatry, 1994, 55, 536-538.
11. Lebert F., Stekke W., Hasenbroekx C i wsp.: Frontotemporaldementia: a randomised, controlled trial with trazodone. Dement. Geriatr. Cogn Disord., 2004, 17, 355-359.
12. Montgomery I., Oswald I., Morgan K. i wsp.: Trazodone enhances sleep in subjective quality but not in objective duration. Br. J. Clin. Pharmacol., 1983, 16, 139-144.
13. Mouret J., Lemoine P., Minuit M.P. i wsp.: Effects of trazodone on the sleep of depressed subjects - a polygraphic study. Psychopharmacology (Berl), 1988, 95 Suppl, S37-S43.
14. Ohayon M.M.: Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med. Rev., 2002, 6, 97-111.
15. Parnowski T., Jernajczyk W.: Inwentarz depresji Beck'a w ocenie nastroju osob zdrowych i chorych na choroby afektywne. Psychiatr. Pol., 1977, 11, 417-421.
16. Parrino L., Spaggiari M.C., Boselli M. i wsp.: Clinical and Polysomnographie effects of trazodone CR in chronic insomnia associated with dysthymia. Psychopharmacology (Berl), 1994, 116, 389-395.
17. Rakel R.E.: The greater safety of trazodone over tricyclic antidepressant agents: 5-year experience in the United States. Psychopathology, 1987, 20 Suppl 1, 57-63.
18. Sadeh A., Acebo C.: The role of actigraphy in sleep medicine. Sleep Med. Rev., 2002, 6, 113-124.
19. Sateia MJ., Nowell P.D.: Insomnia. Lancet, 2004, 364, 1959-1973.
20. Scharf M.B., Sachais B.A.: Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J. Clin. Psychiatry, 1990, 51 Suppl, 13-17.
21. Sheehan D.V., Harnett-Sheehan K., Raj B.A.: The measurement of disability. Int. Clin. Psychopharmacol., 1996, 11 Suppl 3, 89-95.
22. Soldatos CR., Dikeos D.G., Paparrigopoulos T.J.: Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J. Psychosom. Res., 2000, 48, 555-560.
23. Szelenberger W.: Standardy leczenia bezsenności Polskiego Towarzystwa Badań nad Snem. Sen, 2003, 3, 117-126.
24. Tarrasch R., Laudon M., Zisapel N.: Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients. Hum. Psychopharmacol., 2003, 18, 603-610.
25. Ware J.C., Pittard J.T.: Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults. J. Clin. Psychiatry, 1990, 51 Suppl, 18-22.
26. Warner M.D., Dorn M.R., Peabody CA.: Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry, 2001, 34, 128-131.
27. Wichniak A., Murawiec S., Jernajczyk W.: Fannakologiczne leczenie bezsenności. Psychiatr. Pol., 2006, 40, 563-577.
28. Wichniak A., Wierzbicka A., Sobariska A. i wsp.: Niefarmakologiczne metody leczenia bezsenności. Wiad. Psych., 2005, 1, 5 7-62.